Re:Opaque drug pricing in the U.S.
by WalterBright on Sunday March 12, 2017 @10:30PM
(#13854804)
The Atlantic ran an analysis of where the costs go:
https://www.theatlantic.com/magazine/archive/2009/09/how-ame....
Essentially, it's a mess of perverse incentives that are unintended side effects of heavy regulation.
[ Parent
| on HN ]
There are no comments on this comment yet.